{"product_id":"plotkins-vaccines-hardback-9780323790581","title":"Plotkin's Vaccines (Hardback) 9780323790581","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003ePlotkin's Vaccines\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThe gold standard reference on vaccine prevention of targeted infectious and other diseases\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eWalter A. Orenstein (Author), Paul A. Offit (Author), Kathryn M. Edwards (Author), Stanley A. Plotkin (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323790581\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 5 May 2023\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1808 pages, 575\u003cbr\u003e27.6 x 21.6 x 7.5 cm, 3.87 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eFrom the latest vaccination evidence, recommendations, and protocols . . . to new vaccine development and the use of vaccines in reducing disease, Plotkin’s Vaccines, 8th Edition, covers every aspect of vaccination. Now completely revised and updated from cover to cover, this award-winning text continues to provide reliable information from global authorities, offering a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as \"an indispensable guide to the enhancement of the well-being of our world,\" Plotkin’s Vaccines is a must-have reference for current, authoritative information in this fast-moving field.\u003cul\u003e \u003cli\u003e  \u003cp\u003eContains all-new chapters on COVID-19, vaccine hesitancy, and non-specific effects of vaccines, as well as significantly revised content on new vaccine technologies such as mRNA vaccines, emerging vaccines, and technologies to improve immunization. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003ePresents exciting new data on evolution of adjuvants across the centuries, dengue vaccines, human papillomavirus vaccines, respiratory syncytial virus vaccines, tuberculosis vaccines, and zoster vaccines. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eProvides up-to-date, authoritative information on vaccine production, available preparations, efficacy and safety, and recommendations for vaccine use, with rationales and data on the impact of vaccination programs on morbidity and mortality. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eProvides complete coverage of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eKeeps you up to date with information on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eCovers vaccine-preventable diseases, vaccine science, and licensed vaccine products, as well as product technologies and global regulatory and public health issues. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eAnalyzes the cost-benefit and cost-effectiveness of different vaccine options. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eHelps you clearly visualize concepts and objective data through an abundance of tables and figures. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eEnhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices. \u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cb\u003eSECTION I\u003cbr\u003eGeneral Aspects of Vaccination\u003cbr\u003e\u003c\/b\u003e1 A Short History of Vaccination\u003cbr\u003e2 Vaccine Immunology\u003cbr\u003e3 Non-specific Effects of Vaccines\u003cbr\u003e4 Correlates of Protection\u003cbr\u003e5 The Vaccine Industry\u003cbr\u003e6 Vaccine Manufacturing\u003cbr\u003e7 Evolution of Adjuvants Across the Centuries\u003cbr\u003e8 Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States\u003cbr\u003e9 Passive Immunization\u003cbr\u003e\u003cb\u003eSECTION II\u003cbr\u003eLicenced Vaccines and Vaccines in Development\u003cbr\u003e\u003c\/b\u003e10 General Immunization Practices\u003cbr\u003e11 Human Adenovirus Vaccines\u003cbr\u003e12 Anthrax Vaccines\u003cbr\u003e13 Biodefense Vaccines, Vaccines for Emerging Infectious Diseases, and Coalition for Epidemic Preparedness Innovations (CEPI)\u003cbr\u003e14 Cancer Vaccines\u003cbr\u003e15 Cholera Vaccines\u003cbr\u003e16 Combination Vaccines\u003cbr\u003e17 Coronavirus Vaccines\u003cbr\u003e18 Cytomegalovirus Vaccines\u003cbr\u003e19 Dengue Vaccines\u003cbr\u003e20 Vaccines Against Diarrhea Caused by Noncholera Bacteria\u003cbr\u003e21 Diphtheria Toxoid\u003cbr\u003e22 Ebola Vaccines\u003cbr\u003e23 Nonpolio Enteroviruses\u003cbr\u003e24 Epstein–Barr Virus Vaccines\u003cbr\u003e25 Haemophilus Influenzae Type b Vaccines\u003cbr\u003e26 Hepatitis A Vaccines\u003cbr\u003e27 Hepatitis B Vaccines\u003cbr\u003e28 Hepatitis C Vaccines\u003cbr\u003e29 Hepatitis E Vaccines\u003cbr\u003e30 Herpes Simplex Virus Vaccines\u003cbr\u003e31 Human Immunodeficiency Virus Vaccines\u003cbr\u003e32 Human Papillomavirus Vaccines\u003cbr\u003e33 Inactivated and Recombinant Influenza Vaccines\u003cbr\u003e34 Influenza Vaccine—Live\u003cbr\u003e35 Japanese Encephalitis Vaccines\u003cbr\u003e36 Lyme Disease Vaccines—the Journey Continues\u003cbr\u003e37 Malaria Vaccines\u003cbr\u003e38 Measles Vaccines\u003cbr\u003e39 Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines\u003cbr\u003e40 Meningococcal Vaccines Directed at Capsular Group B\u003cbr\u003e41 Mumps Vaccines\u003cbr\u003e42 Noninfectious Disease Vaccines\u003cbr\u003e43 Norovirus\u003cbr\u003e44 Parasitic Disease Vaccines\u003cbr\u003e45 Pertussis Vaccines\u003cbr\u003e46 Plague Vaccines\u003cbr\u003e47 Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines\u003cbr\u003e48 Pneumococcal Polysaccharide Vaccines\u003cbr\u003e49 Poliovirus Vaccine—Inactivated\u003cbr\u003e50 Poliovirus Vaccine—Live\u003cbr\u003e51 Lyssaviruses and Rabies Vaccines\u003cbr\u003e52 Respiratory Syncytial Virus Vaccines and Monoclonal Antibodies\u003cbr\u003e53 Rotavirus Vaccines\u003cbr\u003e54 Rubella Vaccines\u003cbr\u003e55 Smallpox and Vaccinia\u003cbr\u003e56 Staphylococcus aureus Vaccines\u003cbr\u003e57 Streptococcus Group A Vaccines\u003cbr\u003e58 Streptococcus Group B Vaccines\u003cbr\u003e59 Tetanus Toxoid\u003cbr\u003e60 Tickborne Encephalitis Vaccines\u003cbr\u003e61 Tuberculosis Vaccines\u003cbr\u003e62 Typhoid Fever Vaccines\u003cbr\u003e63 Varicella Vaccines\u003cbr\u003e64 Yellow Fever Vaccine\u003cbr\u003e65 Zika Virus Vaccines\u003cbr\u003e66 Zoster Vaccines\u003cbr\u003e\u003cb\u003eSECTION III\u003cbr\u003eNew Technologies\u003c\/b\u003e\u003cbr\u003e67 Technologies for Making New Vaccines\u003cbr\u003e68 Genetic-Based Vaccine Vectors\u003cbr\u003e69 Technologies to Improve Immunization\u003cbr\u003e\u003cb\u003eSECTION IV\u003cbr\u003eVaccination of Special Groups\u003cbr\u003e\u003c\/b\u003e70 Vaccination of Immunocompromised Hosts\u003cbr\u003e71 Vaccines for International Travel\u003cbr\u003e72 Vaccines for Healthcare Personnel\u003cbr\u003e73 Vaccination of Pregnant Women\u003cbr\u003e\u003cb\u003eSECTION V\u003cbr\u003ePublic Health and Regulatory Issues\u003c\/b\u003e\u003cbr\u003e74 Immunization in the United States\u003cbr\u003e75 Immunization in Europe\u003cbr\u003e76 Immunization and Vaccine-Preventable Diseases in the Asia-Pacific Region\u003cbr\u003e77 Immunization in Low- and Middle-Income Countries\u003cbr\u003e78 Community Protection\u003cbr\u003e79 Economic Analyses of Vaccine Policies\u003cbr\u003e80 Regulation and Testing of Vaccines in the US\u003cbr\u003e81 Regulation of Vaccines in Europe\u003cbr\u003e82 Regulation of Vaccines in Low- and Middle-Income Countries\u003cbr\u003e83 Vaccine Safety\u003cbr\u003e84 Vaccine Hesitancy and Behavioral Factors Associated With Vaccine Uptake\u003cbr\u003e85 Legal Issues\u003cbr\u003e86 Ethics\u003cbr\u003e\u003cb\u003eONLINE ONLY\u003c\/b\u003e\u003cbr\u003e87 Vaccines to Prevent Mpox\u003cbr\u003e\u003cb\u003eAPPENDIX\u003c\/b\u003e\u003cbr\u003eWebsites and Applications for Mobile Devices With Information About Immunization\u003cbr\u003e\u003cb\u003eIndex\u003c\/b\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Infectious \u0026amp; contagious diseases [\u003ca title=\"See our other books on Infectious \u0026amp; contagious diseases\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Infectious%20\u0026amp;%20contagious%20diseases%20%5BMJCJ%5D%22\"\u003eMJCJ\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648124309784,"sku":"9780323790581","price":211.98,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323790581_0e20b903-a237-4ba0-a7c4-fcfce81116fd.jpg?v=1694992023","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/plotkins-vaccines-hardback-9780323790581","provider":"Freshly Printed Books","version":"1.0","type":"link"}